• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ACTA2-AS1 通过海绵吸附 miR-378a-3p 和 miR-4428 来抑制肺腺癌进展,从而提高 SOX7 表达。

ACTA2-AS1 suppresses lung adenocarcinoma progression via sequestering miR-378a-3p and miR-4428 to elevate SOX7 expression.

机构信息

Department of Pulmonary and Critical Care Medicine, The First People's Hospital of Wenling, Wenling, Zhejiang, China.

Department of Pediatrics, The First People's Hospital of Wenling, Wenling, Zhejiang, China.

出版信息

Cell Biol Int. 2020 Dec;44(12):2438-2449. doi: 10.1002/cbin.11451. Epub 2020 Oct 7.

DOI:10.1002/cbin.11451
PMID:32808728
Abstract

Lung adenocarcinoma (LUAD) is the most common histological subtype of lung cancer. The abnormal expression of long noncoding RNAs (lncRNAs) can facilitate or suppress the development of malignant tumors. lncRNA actin alpha 2, smooth muscle antisense RNA 1 (ACTA2-AS1) has been reported to function as a tumor suppressor in liver cancer, nevertheless, its influences on LUAD remain to be investigated. In this paper, ACTA2-AS1 was identified as a downregulated lncRNA in LUAD samples and cells. Functionally, ACTA2-AS1 overexpression restrained cell proliferation but accelerated cell apoptosis in LUAD. In addition, we determined the suppressive effect of ACTA2-AS1 on LUAD cell invasion, migration, and epithelial-mesenchymal transition progress. Mechanistically, ACTA2-AS1 exert functions as a competing endogenous RNA through serving as a sponge for microRNA-378a-3p (miR-378a-3p) and microRNA-4428 (miR-4428) to elevate SRY-related high-mobility group box 7 (SOX7) expression. Importantly, SOX7 silencing could recover the ACTA2-AS1-mediated cell functions. To summarize, ACTA2-AS1 suppresses the malignant processes of LUAD cells through sequestering miR-378a-3p and miR-4428 to augment SOX7 expression.

摘要

肺腺癌(LUAD)是肺癌最常见的组织学亚型。长链非编码 RNA(lncRNA)的异常表达可以促进或抑制恶性肿瘤的发展。已有研究报道,lncRNA 肌动蛋白α 2,平滑肌反义 RNA 1(ACTA2-AS1)在肝癌中作为肿瘤抑制因子发挥作用,但它对 LUAD 的影响仍有待研究。在本文中,ACTA2-AS1 被鉴定为 LUAD 样本和细胞中下调的 lncRNA。功能上,ACTA2-AS1 的过表达抑制了 LUAD 细胞的增殖,但加速了细胞凋亡。此外,我们确定了 ACTA2-AS1 对 LUAD 细胞侵袭、迁移和上皮-间充质转化过程的抑制作用。机制上,ACTA2-AS1 通过作为 microRNA-378a-3p(miR-378a-3p)和 microRNA-4428(miR-4428)的海绵,发挥竞争性内源 RNA 的功能,从而提高 SRY 相关高迁移率族盒 7(SOX7)的表达。重要的是,SOX7 的沉默可以恢复 ACTA2-AS1 介导的细胞功能。总之,ACTA2-AS1 通过结合 miR-378a-3p 和 miR-4428 抑制 SOX7 的表达,从而抑制 LUAD 细胞的恶性进程。

相似文献

1
ACTA2-AS1 suppresses lung adenocarcinoma progression via sequestering miR-378a-3p and miR-4428 to elevate SOX7 expression.ACTA2-AS1 通过海绵吸附 miR-378a-3p 和 miR-4428 来抑制肺腺癌进展,从而提高 SOX7 表达。
Cell Biol Int. 2020 Dec;44(12):2438-2449. doi: 10.1002/cbin.11451. Epub 2020 Oct 7.
2
Long non-coding RNA FAM83A antisense RNA 1 (lncRNA FAM83A-AS1) targets microRNA-141-3p to regulate lung adenocarcinoma cell proliferation, migration, invasion, and epithelial-mesenchymal transition progression.长链非编码 RNA FAM83A 反义 RNA 1(lncRNA FAM83A-AS1)靶向 microRNA-141-3p 调控肺腺癌细胞增殖、迁移、侵袭和上皮间质转化进展。
Bioengineered. 2022 Mar;13(3):4964-4977. doi: 10.1080/21655979.2022.2037871.
3
ETV4 mediated lncRNA C2CD4D-AS1 overexpression contributes to the malignant phenotype of lung adenocarcinoma cells via miR-3681-3p/NEK2 axis.ETV4 介导的长链非编码 RNA C2CD4D-AS1 过表达通过 miR-3681-3p/NEK2 轴促进肺腺癌细胞的恶性表型。
Cell Cycle. 2021 Dec;20(24):2607-2618. doi: 10.1080/15384101.2021.2005273. Epub 2021 Dec 1.
4
Long noncoding RNA FBXL19-AS1 induces tumor growth and metastasis by sponging miR-203a-3p in lung adenocarcinoma.长链非编码 RNA FBXL19-AS1 通过海绵吸附 miR-203a-3p 促进肺腺癌的生长和转移。
J Cell Physiol. 2020 Apr;235(4):3612-3625. doi: 10.1002/jcp.29251. Epub 2019 Sep 30.
5
Long noncoding RNA ZFPM2-AS1 is involved in lung adenocarcinoma via miR-511-3p/AFF4 pathway.长链非编码 RNA ZFPM2-AS1 通过 miR-511-3p/AFF4 通路参与肺腺癌的发生。
J Cell Biochem. 2020 Mar;121(3):2534-2542. doi: 10.1002/jcb.29476. Epub 2019 Nov 6.
6
LncRNA TTN-AS1 drives invasion and migration of lung adenocarcinoma cells via modulation of miR-4677-3p/ZEB1 axis.长链非编码RNA TTN-AS1通过调控miR-4677-3p/ZEB1轴驱动肺腺癌细胞的侵袭和迁移。
J Cell Biochem. 2019 Oct;120(10):17131-17141. doi: 10.1002/jcb.28973. Epub 2019 Jun 7.
7
Long noncoding RNA TMPO-AS1 promotes lung adenocarcinoma progression and is negatively regulated by miR-383-5p.长链非编码 RNA TMPO-AS1 促进肺腺癌进展,受 miR-383-5p 的负调控。
Biomed Pharmacother. 2020 May;125:109989. doi: 10.1016/j.biopha.2020.109989. Epub 2020 Feb 13.
8
Long Noncoding RNAs PTPRG Antisense RNA 1 Targets Cyclin D1 to Facilitate Cell Proliferation in Lung Adenocarcinoma.长链非编码 RNA PTPRG 反义 RNA 1 通过靶向细胞周期蛋白 D1 促进肺腺癌细胞增殖。
Cancer Biother Radiopharm. 2024 Oct;39(8):573-583. doi: 10.1089/cbr.2021.0168. Epub 2021 Nov 12.
9
LncRNA TTN-AS1 promotes migration, invasion, and epithelial mesenchymal transition of lung adenocarcinoma via sponging miR-142-5p to regulate CDK5.长链非编码 RNA TTN-AS1 通过海绵吸附 miR-142-5p 调控 CDK5 促进肺腺癌迁移、侵袭和上皮间质转化。
Cell Death Dis. 2019 Jul 30;10(8):573. doi: 10.1038/s41419-019-1811-y.
10
LncRNA SGMS1-AS1 regulates lung adenocarcinoma cell proliferation, migration, invasion, and EMT progression via miR-106a-5p/MYLI9 axis.长链非编码 RNA SGMS1-AS1 通过 miR-106a-5p/MYLI9 轴调控肺腺癌细胞增殖、迁移、侵袭和 EMT 进程。
Thorac Cancer. 2021 Jul;12(14):2104-2112. doi: 10.1111/1759-7714.14043. Epub 2021 Jun 1.

引用本文的文献

1
Human Amniotic Epithelial Stem Cell Exosomes Regulate Chondrocyte Ferroptosis through ACTA2-AS1-Targeted Binding to ACSL4 for Osteoarthritis Intervention.人羊膜上皮干细胞外泌体通过ACTA2-AS1靶向结合ACSL4调控软骨细胞铁死亡以干预骨关节炎
Research (Wash D C). 2025 Aug 8;8:0814. doi: 10.34133/research.0814. eCollection 2025.
2
and as Key Modulators of Insulin Sensitivity and Glucose Homeostasis: Insights into Pathways and Therapeutic Potential in Type 2 Diabetes Mellitus.作为胰岛素敏感性和葡萄糖稳态的关键调节因子:对2型糖尿病途径及治疗潜力的见解
Biology (Basel). 2025 Apr 15;14(4):424. doi: 10.3390/biology14040424.
3
Identification of apoptosisrelated long noncoding RNAs expression profiles in patient with cervical intraepithelial neoplasia 3.
宫颈上皮内瘤变3级患者中凋亡相关长链非编码RNA表达谱的鉴定
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024 Jul 28;49(7):1095-1108. doi: 10.11817/j.issn.1672-7347.2024.230302.
4
Cell components of tumor microenvironment in lung adenocarcinoma: Promising targets for small-molecule compounds.肺腺癌肿瘤微环境的细胞成分:小分子化合物的潜在靶点。
Chin Med J (Engl). 2025 Apr 20;138(8):905-915. doi: 10.1097/CM9.0000000000003341. Epub 2024 Nov 8.
5
[Molecular Mechanism of circVRK1 Regulating the Proliferation and Apoptosis of Acute Lymphoblastic Leukemia KOCL44 Cells by Targeting miR-4428].[环状VRK1通过靶向miR-4428调控急性淋巴细胞白血病KOCL44细胞增殖和凋亡的分子机制]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2024 Jul 20;55(4):872-877. doi: 10.12182/20240760102.
6
Differential expression and clinical significance of long non-coding RNAs in the development and progression of lung adenocarcinoma.长链非编码RNA在肺腺癌发生发展及进展中的差异表达及临床意义
Front Oncol. 2024 Jun 6;14:1411672. doi: 10.3389/fonc.2024.1411672. eCollection 2024.
7
Long non-coding RNA ACTA2-AS1 suppresses metastasis of papillary thyroid cancer via regulation of miR-4428/KLF9 axis.长链非编码 RNA ACTA2-AS1 通过调控 miR-4428/KLF9 轴抑制甲状腺乳头状癌细胞的转移。
Clin Epigenetics. 2024 Jan 9;16(1):10. doi: 10.1186/s13148-023-01622-6.
8
Long Noncoding RNA ACTA2-AS1 Inhibits Cell Growth and Facilitates Apoptosis in Gastric Cancer by Binding with miR-6720-5p to Regulate ESRRB.长链非编码 RNA ACTA2-AS1 通过与 miR-6720-5p 结合调控 ESRRB 抑制胃癌细胞生长并促进细胞凋亡。
Biochem Genet. 2023 Dec;61(6):2672-2690. doi: 10.1007/s10528-023-10399-5. Epub 2023 May 24.
9
A model based on immune-related lncRNA pairs and its potential prognostic value in immunotherapy for melanoma.一种基于免疫相关长链非编码RNA对的模型及其在黑色素瘤免疫治疗中的潜在预后价值。
Funct Integr Genomics. 2023 Mar 20;23(2):91. doi: 10.1007/s10142-023-01029-9.
10
Neutrophil extracellular traps (NETs)-related lncRNAs signature for predicting prognosis and the immune microenvironment in breast cancer.用于预测乳腺癌预后和免疫微环境的中性粒细胞胞外陷阱(NETs)相关长链非编码RNA特征
Front Cell Dev Biol. 2023 Feb 2;11:1117637. doi: 10.3389/fcell.2023.1117637. eCollection 2023.